Adaptimmune Therapeutics plc ADAP

Quarterly report 2025-Q2
added 08-13-2025

Adaptimmune Therapeutics plc DIO Ratio 2011-2026 | ADAP

Quarterly DIO Ratio Adaptimmune Therapeutics plc

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
423	990	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
990	423	706

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Aptorum Group Limited APM	4.89	$ 0.8	1.87 %	$ 4.36 M	China
	Aptevo Therapeutics APVO	112	$ 7.2	-1.64 %	$ 1.99 M	USA
	Aquestive Therapeutics AQST	131	$ 4.1	2.37 %	$ 356 M	USA
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Ardelyx ARDX	989	$ 6.37	-2.75 %	$ 1.54 B	USA
	Arcutis Biotherapeutics ARQT	185	$ 25.33	-6.1 %	$ 3.22 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Atossa Therapeutics ATOS	42.6	$ 4.39	-0.9 %	$ 553 M	USA
	Aurinia Pharmaceuticals AUPH	474	$ 14.14	-0.21 %	$ 1.9 B	Canada
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
	Axon Enterprise AXON	116	$ 570.5	5.18 %	$ 43.2 B	USA
	Axsome Therapeutics AXSM	168	$ 162.28	-0.98 %	$ 8.07 B	USA
	Aytu BioScience AYTU	209	$ 2.56	-0.58 %	$ 16.1 M	USA